Red Glead Discovery AB have appointed Ann Helen Forsling as CFO to strengthen the capacity of its executive management team. Forsling have previously worked at BLS industries as a CFO for the last three years and prior to that...
Read MoreRed Glead Discovery has been recognized as a Gazelle 2021 for the fourth time in five years! Less than 1% of Swedish companies qualify for this “fast-growth-award”. Another great recognition for the fantastic work performed by our engaged co-workers.
Read MoreInterview with Johan Evenäs, CEO of Red Glead Discovery, in Swedens leading Life Science magazine: https://www.lifesciencesweden.se/article/view/810694/red_gleads_vd_vi_var_inga_typiska_entreprenorer_nu_vill_de_vaxa?token=7p8svttcr7zmh6ri8pe78ct4r5hlc5ij
Read More10-year celebrating Red Glead Discovery expects 30% higher turnover for 2021 reflecting increasing customer demand for integrated drug discovery services. Privately held Life Science consultancy company Red Glead Discovery celebrates its 10-year anniversary this month. This important milestone could...
Read MoreFor the third time, experts within the field of peptides in the Öresund region as well as the surrounding Nordic countries were gathering in Lund to present and discuss their current research. Peptides represent a unique niche for developing...
Read MoreApoGlyx, a company co-founded by RGD wins prestigious NLSInvest Rising Star Award 2021. Featured in Nordic Life Science News. https://nordiclifescience.org/interview-the-winners-of-the-nlsinvest-rising-star-award/
Read MoreFeature in News Öresund profiling RGD as one of several fast-growing life science companies from the Lund/Malmö region. Includes details on the opening of a new office space at Copenhagen Bio Science Park (COBIS) for increased presence in Denmark....
Read More